Skip to main content
Premium Trial:

Request an Annual Quote

Toronto Health Clinic to Offer GeneNews' Colorectal Cancer Test

NEW YORK (GenomeWeb News) - Scienta Health, a Toronto-based health clinic, will offer GeneNews’ colorectal cancer risk-assessment test to its patients, GeneNews said today.
 
Scienta will offer ColonSentry to its clients as an “optional component” in their annual health assessments, Toronto-based GeneNews said.
 
Elaine Chin, chief medical officer and co-founder of Scienta Health, said in a statement that ColonSentry “provides a more accurate and reliable basis for recommending colonoscopies than demographic benchmarks or the less sophisticated occult blood stool test.”
 
Heiner Dreismann, interim CEO and lead director of GeneNews, said that the partnership with Scienta is an example of “one component” of the company’s commercialization strategy for ColonSentry. “In the coming months, we expect to roll out our test in additional regions in Canada and target private health insurers to include our test under their healthcare offerings,” he said.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.